Organization
NovaRock Biotherapeutics
2 clinical trials
Clinical trial
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Anti-tumor Activity of NBL-020 Injection in Subjects With Advanced Malignant Tumors.Status: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of NBL-028 in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2027-01-01